Encompass Health Co. (NYSE:EHC) to Post Q2 2024 Earnings of $0.96 Per Share, William Blair Forecasts

Encompass Health Co. (NYSE:EHC) – William Blair reduced their Q2 2024 earnings estimates for Encompass Health in a research report issued to clients and investors on Wednesday, April 24th. William Blair analyst J. Haase now expects that the company will earn $0.96 per share for the quarter, down from their previous forecast of $0.97. William Blair has a “Outperform” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $4.04 per share. William Blair also issued estimates for Encompass Health’s Q3 2024 earnings at $0.94 EPS, Q4 2024 earnings at $0.99 EPS, FY2024 earnings at $4.01 EPS, Q3 2025 earnings at $1.07 EPS, Q4 2025 earnings at $1.13 EPS and FY2025 earnings at $4.58 EPS.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. The business had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The business’s revenue for the quarter was up 13.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.88 EPS.

Several other research analysts have also recently commented on the stock. Raymond James restated a “strong-buy” rating and issued a $95.00 target price (up previously from $85.00) on shares of Encompass Health in a research report on Friday. Stephens reiterated an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a research report on Tuesday, January 16th. Truist Financial raised their price target on Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a report on Friday, February 9th. Mizuho upped their price objective on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $83.00 target price on shares of Encompass Health in a research note on Friday, February 9th. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $86.56.

Encompass Health Stock Down 0.3 %

Encompass Health stock opened at $82.47 on Friday. The firm has a market capitalization of $8.26 billion, a P/E ratio of 22.29, a P/E/G ratio of 1.50 and a beta of 0.94. The company has a 50-day simple moving average of $78.25 and a 200-day simple moving average of $70.91. Encompass Health has a one year low of $57.55 and a one year high of $85.84. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.28 and a current ratio of 1.37.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Principal Securities Inc. purchased a new stake in Encompass Health during the fourth quarter valued at about $25,000. Benjamin F. Edwards & Company Inc. boosted its stake in Encompass Health by 360.2% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock worth $27,000 after purchasing an additional 317 shares during the period. McGlone Suttner Wealth Management Inc. acquired a new position in Encompass Health in the 4th quarter worth approximately $30,000. GAMMA Investing LLC purchased a new position in Encompass Health during the 4th quarter worth approximately $33,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in Encompass Health during the 3rd quarter valued at $35,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a $0.15 dividend. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.73%. Encompass Health’s dividend payout ratio is currently 16.22%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.